Status:
COMPLETED
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Contraception
Eligibility:
FEMALE
18-49 years
Phase:
PHASE3
Brief Summary
To evaluate the safety and contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen.
Eligibility Criteria
Inclusion
- Healthy women aged 18 to 49 years
- Regular (21- to 35- day) menstrual cycles for the 3-month period preceding visit 1
- Must be sexually active and at risk for becoming pregnant.
Exclusion
- Planned use of any other form of birth control other than the test article.
- Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.
- High blood pressure (defined as elevated sitting blood pressure: \> 140/90 mm Hg).
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00245921
Start Date
February 1 2003
End Date
October 1 2005
Last Update
February 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.